Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Feb;14(2):210-6.
doi: 10.3201/eid1402.070725.

Effectiveness of personal protective measures to prevent Lyme disease

Affiliations

Effectiveness of personal protective measures to prevent Lyme disease

Marietta Vázquez et al. Emerg Infect Dis. 2008 Feb.

Abstract

After the manufacture of Lyme vaccine was discontinued in 2002, strategies to prevent Lyme disease (LD) have focused on personal protective measures. Effectiveness of these measures has not been conclusively demonstrated. The aim of our case-control study was to assess the effectiveness of personal preventive measures in a highly disease-endemic area. Case-patients were persons with LD reported to Connecticut's Department of Public Health and classified as having definite, possible, or unlikely LD. Age-matched controls without LD were identified. Study participants were interviewed to assess the practice of preventive measures and to obtain information on occupational and recreational risk factors. Use of protective clothing was 40% effective; routine use of tick repellents on skin or clothing was 20% effective. Checking one's body for ticks and spraying property with acaricides were not effective. We concluded that use of protective clothing and of tick repellents (on skin or clothing) are effective in preventing LD.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Orloski KA, Hayes EB, Campbell GL, Dennis DT. Surveillance for Lyme disease—United States, 1992–1998. MMWR Surveill Summ. 2000;49:1–11. - PubMed
    1. Centers for Disease Control and Prevention. Lyme disease—United States, 2001–2002. MMWR Morb Mortal Wkly Rep. 2004;53:365–9. - PubMed
    1. Steere AC, Sikand VK, Meurice F, Parenti DL, Fikrig E, Schoen RT, et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. N Engl J Med. 1998;339:209–15. 10.1056/NEJM199807233390401 - DOI - PubMed
    1. Hayes EB, Piesman J. How can we prevent Lyme disease? N Engl J Med. 2003;348:2424–30. 10.1056/NEJMra021397 - DOI - PubMed
    1. Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, et al. The clinical assessment, treatment and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43:1089–134. 10.1086/508667 - DOI - PubMed

Publication types

MeSH terms